To address whether the glycopeptide conjugate antisera is capable of recognizing Her2 in its cell membrane form, flow cytometry was performed using Her2 expressing human breast carcinoma cells (SKBR3) (Fig. 9). The gene discussed is ERBB2; the disease is breast carcinoma.